Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP756713.RAcjA6JG832KR-KtMXRiBDJqgKHfytXLUMR6HvEmEZbzA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP756713.RAcjA6JG832KR-KtMXRiBDJqgKHfytXLUMR6HvEmEZbzA130_assertion type Assertion NP756713.RAcjA6JG832KR-KtMXRiBDJqgKHfytXLUMR6HvEmEZbzA130_head.
- NP756713.RAcjA6JG832KR-KtMXRiBDJqgKHfytXLUMR6HvEmEZbzA130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756713.RAcjA6JG832KR-KtMXRiBDJqgKHfytXLUMR6HvEmEZbzA130_provenance.
- NP756713.RAcjA6JG832KR-KtMXRiBDJqgKHfytXLUMR6HvEmEZbzA130_assertion evidence source_evidence_literature NP756713.RAcjA6JG832KR-KtMXRiBDJqgKHfytXLUMR6HvEmEZbzA130_provenance.
- NP756713.RAcjA6JG832KR-KtMXRiBDJqgKHfytXLUMR6HvEmEZbzA130_assertion SIO_000772 12459031 NP756713.RAcjA6JG832KR-KtMXRiBDJqgKHfytXLUMR6HvEmEZbzA130_provenance.
- NP756713.RAcjA6JG832KR-KtMXRiBDJqgKHfytXLUMR6HvEmEZbzA130_assertion wasDerivedFrom befree-20150227 NP756713.RAcjA6JG832KR-KtMXRiBDJqgKHfytXLUMR6HvEmEZbzA130_provenance.
- NP756713.RAcjA6JG832KR-KtMXRiBDJqgKHfytXLUMR6HvEmEZbzA130_assertion wasGeneratedBy ECO_0000203 NP756713.RAcjA6JG832KR-KtMXRiBDJqgKHfytXLUMR6HvEmEZbzA130_provenance.